Using Losartan to Reduce Knee Scarring After Surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of Losartan in preventing arthrofibrosis following total knee arthroplasty (TKA). It is a double-blind, randomized, placebo-controlled study involving 120 patients who will be monitored for changes in knee range of motion and capsular thickening post-surgery. Participants will be randomly assigned to receive either Losartan or a placebo to assess the drug's impact on recovery outcomes. The study aims to provide insights into improving patient-reported outcomes after knee surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Planned primary total knee arthroplasty of a single knee;
2. Male or female ≥ 18 years of age;
3. Capacity to personally give informed consent (consent via legally authorized representative will not be accepted) and who are willing to comply with all study-related procedures and assessments.

Exclusion Criteria:

1. Breastfeeding, pregnant, or planning to become pregnant during participation in the study;
2. Diagnosed with inflammatory or other arthritis caused by autoimmune disease affecting the study knee;
3. Previous knee arthroplasty on the study knee;
4. Previous infection affecting the study knee;
5. Planned total knee arthroplasty of contralateral knee to occur at any point during the study participation period;
6. Are hypotensive as confirmed by Principal Clinical Investigator or appropriate designee;
7. Planned lower extremity surgery (other than TKA in the study leg) for the duration of study participation;
8. Any condition other than knee osteoarthritis that significantly impairs ability to walk or perform other activities of daily living;
9. Currently taking: Losartan or other medication in the same drug class; Warfarin or related anticoagulants;
10. Opioid analgesics taken in the past 8 weeks and are not willing to discontinue these medications through the duration of the study (except as prescribed as standard of care in the immediate post-operative period);
11. Allergic to any active or inactive ingredient of Losartan;
12. Taking medication with known adverse Losartan interaction;
13. Subjects that have any medical condition, including malignancies, laboratory findings, and/or findings in the medical history or in the pre-study assessments that, in the opinion of the Investigator, constitutes a risk or contraindication for participation in the study or that could interfere with the study objectives, conduct, or evaluation, or prevent the patient from fully participating in all aspects of the study.

Where it's running

• The Steadman Clinic
  Vail, Colorado, United States Recruiting

Study contacts

• Principal investigator: Johnny Huard, PhD — Steadman Philippon Research Institute
• Study coordinator: Suzanne L Page, JD
• Email: spage@sprivail.org
• Phone: 970-401-8770

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adductor canal block versus adductor canal plus IPACK block for pain after total knee replacement

  This study will test whether adding an IPACK block to an adductor canal block reduces pain and the need for pain medicine after total knee replacement.

  Recruiting at 2 sites TC Erciyes University · Kayseri, Talas and 1 other locations · NCT07526831

• 12-month effects of keeping the posterior cruciate ligament during MAKO robotic-assisted total knee replacement

  This trial tests whether keeping the posterior cruciate ligament during MAKO robotic-assisted total knee replacement leads to better function at 12 months for people having a first-time unilateral knee replacement.

  Recruiting at 3 sites Centre Hospitalier Universitaire de Nīmes · Bordeaux and 2 other locations · NCT07489963

• Post-Operative Pain Relief with Zynrelef vs Periarticular Injections in Robot-Assisted Knee Replacement

  This study tests whether the Zynrelef extended-release periarticular injection can reduce pain and opioid use after robot-assisted total knee arthroplasty compared with standard periarticular injections.

  Recruiting Phase 4 Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Cranberry Township, Pennsylvania · NCT07430085

• Cryoneurolysis before total knee replacement surgery

  This trial will test whether freezing the genicular nerves at least 24 hours before total knee replacement reduces long-term pain and improves recovery for adults having primary TKA for osteoarthritis.

  Recruiting Attikon Hospital · Athens · NCT07425457

• Types of persistent pain after hip or knee replacement

  We will re-contact people who still have moderate-to-severe pain after hip or knee replacement to see whether their pain shows signs of nociceptive, neuropathic, or nociplastic mechanisms.

  Recruiting Copenhagen University Hospital, Rigshospitalet · Østerbro, København Ø · NCT07110324

• Low-dose epinephrine with tranexamic acid during knee replacement

  This will test whether giving low-dose epinephrine together with tranexamic acid to people having knee replacement reduces blood loss, clotting complications, and hospital stay.

  Recruiting Phase 4 King Abdullah International Medical Research Center · Riyadh, Riyadh Region · NCT07089251

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.